Magic mushroom compound could ease pelvic pain in women
NCT ID NCT06988319
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This early-stage study will test whether a single dose of psilocybin (25 mg) combined with therapy sessions is safe and feasible for women aged 18-45 with chronic pelvic pain that hasn't improved with standard treatments. The study involves 15 participants and focuses on recruitment, safety, and pain's impact on daily life. It is not a cure but aims to ease symptoms and improve quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PELVIC PAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pelvic floor therapy put to the test against endometriosis pain
- Pelvic floor muscle function may hold key to endometriosis pain
- Could a common muscle relaxant cut narcotic use after hysterectomy?
- New imaging method could improve pelvic pain treatment
- Podcast therapy: a new hope for pelvic pain sufferers?
- Bladder microbiome study aims to unlock secrets of urinary diseases